BOSTON & SOUTH SAN FRANCISCO, Calif. & MUMBAI, India--(BUSINESS WIRE)--MPM Capital, L.P., a US-based global investment management firm focused solely on healthcare investing, and Reliance Life Sciences (RLS), part of India’s largest private sector business group, today announced a partnership to build India’s life sciences sector. Making its first investment in venture capital, Reliance has become a Limited Partner in MPM Capital’s newest fund, MPM BioVentures IV. Working closely with RLS, MPM Capital said it expects to target a portion of the BioVentures IV fund’s international allocation to invest selectively in emerging life science companies in India, to provide office space for a RLS investment professional dedicated to the MPM/RLS partnership, and to explore the potential for a new India-only seed fund.
